RUNX3 and ovarian cancer: The methylation of opioid-binding protein/cell adhesion molecules like OPCML, Runt-related transcription factor 3 (RUNX3), and tissue factor pathway inhibitor 2 (TFPI2) genes was studied in ovarian cancer patients using methylation-specific NGS.